CD79A and infection: By comparing circulating IgA anti-SARS-CoV-2 S levels in subjects who became infected after vaccination to levels in those who remained uninfected, we tested whether circulating IgA anti-SARS-CoV-2 S or IgA anti-SARS-CoV-2 S receptor binding domain (RBD) levels can predict protection from infection.